单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China华中科技大学同济医学院附属同济医院[2]Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China[3]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China[4]Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China[5]Capital Med Univ, Youan Hosp, Beijing, Peoples R China[6]China Med Univ, Shengjing Hosp, Shenyang, Liaoning, Peoples R China中国医科大学盛京医院[7]Xiamen Amoytop Biotech Co Ltd, Xiamen, Fujian, Peoples R China[8]Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Hubei, Peoples R China
第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
Wu Di,Yan Weiming,Tan Deming,et al.COMBINATION OF NA, PEG-IFN ALPHA-2b AND GMCSF ENHANCED HBSAB PRODUCTION IN NA SUPPRESSED CHB PATIENTS (THE ANCHOR A STUDY): AN INTERIM ANALYSIS[J].HEPATOLOGY.2019,70:104A-104A.
APA:
Wu, Di,Yan, Weiming,Tan, Deming,Peng, Shifang,Chen, Yongping...&Ning, Qin.(2019).COMBINATION OF NA, PEG-IFN ALPHA-2b AND GMCSF ENHANCED HBSAB PRODUCTION IN NA SUPPRESSED CHB PATIENTS (THE ANCHOR A STUDY): AN INTERIM ANALYSIS.HEPATOLOGY,70,
MLA:
Wu, Di,et al."COMBINATION OF NA, PEG-IFN ALPHA-2b AND GMCSF ENHANCED HBSAB PRODUCTION IN NA SUPPRESSED CHB PATIENTS (THE ANCHOR A STUDY): AN INTERIM ANALYSIS".HEPATOLOGY 70.(2019):104A-104A